首页>
外国专利>
Single administration of 1.5 mg levonorgestrel increases compliance and decreases possibility of incorrect use of this post-coital contraceptive
Single administration of 1.5 mg levonorgestrel increases compliance and decreases possibility of incorrect use of this post-coital contraceptive
展开▼
机译：一次服用1.5 mg左炔诺孕酮可提高依从性，并减少不正确使用这种性交后避孕药的可能性
展开▼
页面导航
摘要
著录项
相似文献
摘要
A dosage regimen for emergency contraception, pharmaceutical compositions of the same purpose, the use of levenorgestrel for the manufacture of pharmaceutical compositions for the same purpose, as well as to the manufacturing process of these pharmaceutical compositions are described. The emergency contraception carried out by the use of levonorgestrel as active ingredient is characterised by administering a single application dose containing 1.5 +/- 0.2 mg of levonorgestrel up to 72 hours after the coitus. These pharmaceutical compositions for emergency contraception contain only 1.5 +/- 0.2 mg of levonorgestrel as the active ingredient in each application dose in admixture with known excipients, diluents, flavouring or aromatizing, stabilizers, as well as formulation-promoting or formulation-providing additives, commonly used in the pharmaceutical practice.
展开▼
